Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10Q - Heyu Biological Technology Corp | heyu10q2630_10q.htm |
| EX-32.1 - EXHIBIT 32.1 - Heyu Biological Technology Corp | exhibit312_ex32z1.htm |
| EX-31.2 - EXHIBIT 31.2 - Heyu Biological Technology Corp | exhibit312_ex31z2.htm |
| EX-31.1 - EXHIBIT 31.1 - Heyu Biological Technology Corp | exhibit311_ex31z1.htm |
EXHIBIT 32.02
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Heyu Biological Technology Corporation (the “Company”), for the quarter ended June 30, 2018, as filed with the Securities and Exchange Commission (the “Report”), the undersigned, Wendy Li, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Dated: August 14, 2018
By: /s/ Wendy Li
_________________________________
Wendy LI
CFO